Description
Recombinant Human B29/CD79B Protein
The Recombinant Human B29/CD79B Protein is a biologically active recombinant protein that plays a significant role in various cellular processes and signaling pathways in human biology. This protein is widely employed in immunological research, cell biology studies, protein-protein interaction analyses, and therapeutic development, providing researchers with a reliable tool for investigating B29/CD79B function and its implications in health and disease.
This product (SKU: RPCB1237) is produced using HEK293 cells and features a C-hFc tag for convenient detection and purification. The protein exhibits a calculated molecular weight of 41.16 kDa with an observed molecular weight of 55-65kDa under denaturing conditions, achieving ≥ 95 % as determined by SDS-PAGE;≥ 90 % as determined by HPLC.. Functional bioactivity has been validated through rigorous quality control assays, confirming its suitability for demanding research applications.
Key Features
| High Purity by Affinity Chromatography | |
| Mammalian & Bacterial Expression Systems | |
| High lot-to-lot consistency via strict QC | 
| Product Name: | Recombinant Human B29/CD79B Protein | 
| SKU: | RPCB1237 | 
| Size: | 10 μg , 20 μg , 50 μg , 100 μg | 
| Reactivity: | Human | 
| Synonyms: | AGM6, B29, IGB, CD79B, B29, IGB | 
| Tag: | C-hFc | 
| Expression Host: | HEK293 cells | 
| Calculated MW: | 41.16 kDa | 
| Observed MW: | 55-65kDa | 
| Gene ID: | 974 | 
| Protein Description: | High quality, high purity and low endotoxin recombinant Recombinant Human B29/CD79B Protein (RPCB1237), tested reactivity in HEK293 cells and has been validated in SDS-PAGE.100% guaranteed. | 
| Endotoxin: | < 0.1 EU/μg of the protein by LAL method. | 
| Purity: | ≥ 95 % as determined by SDS-PAGE;≥ 90 % as determined by HPLC. | 
| Formulation: | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. | 
| Bio-Activity: | Measured by its binding ability in a functional ELISA. Immobilized Human CD79B at 2 μg/mL (100 μL/well) can bind Anti-CD79B Humanized Antibody with a linear range of 0.781-1.771 ng/mL. | 
| Reconstitution: | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. | 
| Storage: | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. | 
B-cell antigen receptor complex-associated protein beta chain (CD79B) is also known as B-cell-specific glycoprotein B29, Ig-beta,Immunoglobulin-associated B29 protein, B29 and IGB, which is a single-pass type I membrane protein containing one Ig-like V-type ( immunoglobulin-like ) domain and one ITAM domain.CD79b is required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR).CD79b can enhance phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. Defects in CD79b are the cause of agammaglobulinemia type 6 (AGM6) that is a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development.
            
            

